S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
S&P 5005,963+0.54%
NASDAQ21,443+0.87%
DOW43,892+0.31%
DAX23,888+0.44%
FTSE 1008,721-0.12%
EUR/USD1.1465+0.07%
GBP/USD1.3220+0.14%
USD/JPY161.31-0.03%
Gold3,241+0.22%
WTI Oil76.40+0.81%
Bitcoin103,241+1.43%
10Y UST4.47%-9bp
MarketsFN
Home/Hedge Funds/Deep Track Capital/Q1 2022

Deep Track Capital

Period: Q1 2022 Β· Filed: 2022-05-16
View on SEC EDGAR β†—
AUM
$1.56B
Total portfolio value
Positions
52
Reported securities
Top Holding
NVCR
5.3% $82.8M
QoQ Changes
+8 / -8
new Β· exited
⚠️13F Filing Disclosure

AUM figures shown are calculated by summing the reported market value of all positions in SEC 13F-HR filings β€” not the fund's actual assets under management.

  • Excludes cash, bonds, private equity, short positions, and foreign-listed stocks not required to be reported.
  • For PUT and CALL options, the reported Value is the notional value of the underlying shares β€” not the option premium paid. This significantly overstates the actual capital at risk.
  • Actual fund AUM is typically higher and includes strategies, instruments, and positions that never appear in a 13F.
  • 13F filings cover institutional managers with β‰₯$100M in 13F securities. Positions reflect end-of-quarter holdings, disclosed up to 45 days after the period ends.

Data sourced from SEC EDGAR. This tracker is for informational purposes only and does not constitute investment advice.

Portfolio Holdings

Top 30 positions

⚠️ Performance % calculated from filing date ( 2022-05-16) shown is the underlying stock price movement β€” not the derivative's P&L.
TickerIssuerNotionalPort %@ FilingNow (EOD)Since FilingAllocation
NVCRNOVOCURE LTD$82.8M5.31%$82.85$17.20-79.2%
5.3%
BCYCBICYCLE THERAPEUTICS PLC$81.4M5.22%$43.88$4.35-90.1%
5.2%
TVTXTRAVERE THERAPEUTICS INC$80.8M5.18%$25.77$56.92+120.9%
5.2%
JAZZJAZZ PHARMACEUTICALS PLC$80.5M5.16%$155.67$243.47+56.4%
5.2%
GBTGLOBAL BLOOD THERAPEUTICS IN$79.8M5.12%β€”β€”
5.1%
FATEFATE THERAPEUTICS INC$77.5M4.97%$38.77$2.92-92.5%
5.0%
MDGLMADRIGAL PHARMACEUTICALS INC$77.1M4.95%$98.12$528.10+438.2%
5.0%
ISEEIVERIC BIO INC$75.7M4.86%β€”β€”
4.9%
ALNYALNYLAM PHARMACEUTICALS INC$75.7M4.86%$163.29$312.78+91.5%
4.9%
KROSKEROS THERAPEUTICS INC$75.1M4.81%$54.38$11.26-79.3%
4.8%
KURAKURA ONCOLOGY INC$54.9M3.52%$16.08$11.10-31.0%
3.5%
KDNYCHINOOK THERAPEUTICS INC$49.1M3.15%β€”β€”
3.1%
BEAMBEAM THERAPEUTICS INC$43.8M2.81%$57.30$34.79-39.3%
2.8%
IMVTIMMUNOVANT INC$39.8M2.55%$5.51$38.79+604.0%
2.5%
RPTXREPARE THERAPEUTICS INC$37.9M2.43%β€”β€”
2.4%
FDMT4D MOLECULAR THERAPEUTICS IN$37.0M2.37%$15.12$13.00-14.0%
2.4%
AGENAGENUS INC$34.4M2.21%$48.28$3.49-92.8%
2.2%
CRNXCRINETICS PHARMACEUTICALS IN$33.8M2.17%$21.95$42.23+92.4%
2.2%
DYNDYNE THERAPEUTICS INC$33.7M2.16%$9.64$23.07+139.3%
2.2%
JNCEJOUNCE THERAPEUTICS INC$28.9M1.85%β€”β€”
1.9%
ESPRESPERION THERAPEUTICS INC NE$27.8M1.79%$4.64$3.16-31.9%
1.8%
KALVKALVISTA PHARMACEUTICALS INC$25.5M1.64%$14.74β€”
1.6%
NKTXNKARTA INC$24.1M1.54%$11.38$3.22-71.7%
1.5%
DICEDICE THERAPEUTICS INC$23.9M1.53%β€”β€”
1.5%
SAGESAGE THERAPEUTICS INC$22.3M1.43%β€”β€”
1.4%
TCDAQTRICIDA INC$21.8M1.40%β€”β€”
1.4%
VRDNVIRIDIAN THERAPEUTICS INC$21.6M1.39%$18.49$19.40+4.9%
1.4%
SLNSILENCE THERAPEUTICS PLC$18.1M1.16%$19.00$10.39-45.3%
1.2%
MGTAMAGENTA THERAPEUTICS INC$15.5M1.00%β€”β€”
1.0%
FMTXFORMA THERAPEUTICS HLDGS INC$15.4M0.99%β€”β€”
1.0%

Quarter-on-Quarter Activity

Q1 2022 vs. Q4 2021

New Positions (8)

TickerIssuerNotionalSince Filing
AGENAGENUS INC$34.4M-92.8%
FMTXFORMA THERAPEUTICS HLDGS INC$15.4M
ENTAENANTA PHARMACEUTICALS INC$14.2M
ANABANAPTYSBIO INC$13.8M
HOOKHOOKIPA PHARMA INC$11.5M
RXDXPROMETHEUS BIOSCIENCES INC$9.3M
NUVBNUVATION BIO INC$6.1M
RLMDRELMADA THERAPEUTICS INC$2.8M

Exited Positions (8)

TickerIssuerNotional
RNAMAVIDITY BIOSCIENCES INC$23.8M
ACADACADIA PHARMACEUTICALS INC$23.3M
KRTXKARUNA THERAPEUTICS INC$17.1M
SRRASIERRA ONCOLOGY INC$13.2M
ATRAATARA BIOTHERAPEUTICS INC$11.8M
ASNDASCENDIS PHARMA A/S$10.8M
VNDAVANDA PHARMACEUTICALS INC$7.8M
VNDAVANDA PHARMACEUTICALS INC$7.8M

Increased (8)

TickerIssuerNotionalShares Ξ”Since Filing
ALNYALNYLAM PHARMACEUTICALS INC$73.7M+3862.9%+91.5%
FATEFATE THERAPEUTICS INC$53.1M+378.4%-92.5%
IPSCCENTURY THERAPEUTICS INC$7.7M+270.6%
NKTRPUTNEKTAR THERAPEUTICS$-1.4M+100.0%
NVCRNOVOCURE LTD$41.6M+81.8%-79.2%
SAGESAGE THERAPEUTICS INC$5.3M+68.8%
BCYCBICYCLE THERAPEUTICS PLC$14.5M+68.7%-90.1%
GRTSQGRITSTONE BIO INC$-10.5M+68.5%

Trimmed (8)

TickerIssuerNotionalShares Ξ”Since Filing
VERVVERVE THERAPEUTICS INC$-16.1M-79.5%
PTGXPUTPROTAGONIST THERAPEUTICS INC$-10.9M-64.8%
RFLRAFAEL HLDGS INC$-1.2M-63.5%
TNYATENAYA THERAPEUTICS INC$-8.0M-28.3%
CRNXCRINETICS PHARMACEUTICALS IN$-20.1M-18.9%+92.4%
FULCFULCRUM THERAPEUTICS INC$2.1M-13.3%
VRDNVIRIDIAN THERAPEUTICS INC$-4.8M-12.4%+4.9%
DICEDICE THERAPEUTICS INC$-10.0M-6.8%
← Back to Hedge Funds